The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

✍ Scribed by Leskela, S.; Leandro-Garcia, L. J.; Mendiola, M.; Barriuso, J.; Inglada-Perez, L.; Munoz, I.; Martinez-Delgado, B.; Redondo, A.; de Santiago, J.; Robledo, M.; Hardisson, D.; Rodriguez-Antona, C.

• Book ID: 118167224
• Publisher: Bioscientifica
• Year: 2010
• Tongue: English
• Weight: 285 KB
• Volume: 18
• Category: Article
• ISSN: 1351-0088
• DOI: 10.1677/erc-10-0148